Addiction treatment drug maker Indivior said it had agreed to pay $385m to resolve the final lawsuit claims against it in the long-running Suboxone anti-trust case.
Indivior PLC (OTCMKTS:INVVY – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.85, with a volume of 8,100 shares trading hands. Indivior Stock Performance The […]
Shares of Indivior PLC (NASDAQ:INDV – Get Free Report) fell 6.6% on Tuesday . The company traded as low as $20.42 and last traded at $20.42. 2,663 shares changed hands during trading, a decline of 73% from the average session volume of 9,720 shares. The stock had previously closed at $21.87. Analyst Ratings Changes Separately, […]
Digital therapeutics developer Click Therapeutics is partnering with Indivior to develop a mobile app for substance use disorder. Indivior is now Clickâs third development partner, following deals with Boehringer Ingelheim and Otsuka Pharmaceutical.